THERMO FISHER SCIENTIFIC to acquire SOLVENTUM (PURIFICATION & FILTRATION BUSINESS)

Thermo Fisher Scientific has agreed to acquire the Purification and Filtration business of Solventum in a strategic acquisition. The transaction involves the transfer of operations within the chemical manufacturing and laboratory instrumentation sectors, specifically covering NACE codes C 26.51, C 32.5, and C 20. The deal was announced on 15 June 2025, marking a significant expansion for the buyer into these specialised industrial segments. No financial consideration or deal value was disclosed in the public announcement, and the specific country of the target operations remains unreported.

The transaction is currently in the review phase pending necessary regulatory approvals. Completion has not yet been confirmed as the deal status remains in review. This acquisition represents a strategic move to integrate advanced purification technologies into the buyer's existing portfolio without a disclosed financial premium. The management team of the target business will transition to the acquiring entity upon successful closure. Further details regarding the specific terms of the agreement are not available at this time.